Moneycontrol PRO
Check Credit Score
Check Credit Score
HomeNewsBusinessEconomy

COVID-19 Impact: Insurance premium volumes will recover only by 2021, says Swiss Re sigma study

As per the latest Swiss Re sigma report, India's insurance density stood at USD 78 in FY20. The report said that emerging economies will bounce back quicker.

July 09, 2020 / 08:44 PM IST

Insurance premium volumes will return to pre-COVID-19 levels by 2021, a sigma study by Swiss Re Institute hopes.

The study said, the sharpest economic contraction since the 1930s will lead to a slump in demand for insurance in 2020, more so for life products, with global premiums expected to contract by 6 percent, than for non-life covers (-0.1 percent).

“The magnitude of premium losses will be similar to that seen during the global financial crisis in 2008-09, even though this year's economic contraction of around 4 percent will be much more severe. Unlike for the global economy, we expect a strong V-shaped recovery in insurance premiums, a remarkable showing considering that the world is currently in the throes of the deepest recession ever,” said Jerome Jean Haegeli, Group Chief Economist at Swiss Re.

The sigma study said, this year's recession will be the deepest since the Great Depression of the 1930s, but it will also be short-lived. The recession will lead to a steep fall in demand for insurance. After growing by 2.2 percent in 2019, global life premiums are forecast to contract by 6 percent in 2020.

Further, the report said that due to prevailing and lower interest rates, savings products will be more affected, while mortality related covers (term plans) will be more stable.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Emerging Asia, led by China, to underpin market resilience through 2021

Swiss Re Institute estimates that total premium volumes in advanced markets (life and non-life) will shrink by 4 percent this year and return to positive growth of more than 2 percent in 2021.

Top 15 insurance

But in the emerging markets, it said that premium growth will remain in positive territory in both years, up 1 percent in 2020 and 7 percent in 2021.

Looking at a long-term view, the sigma report said that the ongoing shift in global insurance market opportunity to emerging Asia and China in particular, will continue.

The report said that excluding medical insurance premiums, China remains on track to become the largest insurance market globally by the mid-2030s.

“By then India, another emerging giant, will also be among the 10 largest insurance markets of the world,” said the report. Right now, India is at the 11th position globally with total premium volume of $106 billion.

Insurance penetration, density flat in India

When it comes to the insurance penetration and density, the figures for India were flat as per the Swiss Re’s sigma report.

Insurance density which is premium per capita stood at $78 (approximately Rs 5,850) in FY20 compared to $ 74 (approximately Rs 5,550). The world average was USD 818 (Rs 61,350 approximately).

Insurance penetration (premiums as a percentage of gross domestic product) stood at 3.76 percent  in India for FY20. Life insurance penetration was at 2.82 percent while that for non-life stood at 0.94 percent.

The world average was 7.23 percent with 3.55 percent for life and 3.88 percent for non-life insurance.

In FY19, India had insurance penetration of 3.7 percent with 2.74 percent for life and 0.97 percent for non-life.

Insurance industry will absorb the earnings shock

When it comes to the pandemic, there has already been a slew of claims related to hospitalisation as well as business losses filed.

The sigma report said that there is uncertainty about what the ultimate claims burden from the pandemic will be, with the mid-point of the range of current estimates from various external and public sources at around $55 billion. However, it added that the insurance industry is very well capitalised to absorb losses.

"The industry's capital position means it should be able to handle the COVID-19 shock. The upper end of the range of total property and casualty claims estimates by most external insurance analysis is $100 billion, similar in scale to losses caused by Hurricanes Harvey, Irma and Maria in 2017, which the industry also absorbed," Haegeli said.

Moneycontrol News
first published: Jul 9, 2020 08:42 pm

Discover the latest business news, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347